Your browser doesn't support javascript.
Temporal differences in culturable severe acute respiratory coronavirus virus 2 (SARS-CoV-2) from the respiratory and gastrointestinal tracts in a patient with moderate coronavirus disease 2019 (COVID-19).
Audsley, Jennifer M; Holmes, Natasha E; Mordant, Francesca L; Douros, Celia; Zufan, Sara E; Nguyen, Thi H O; Kedzierski, Lukasz; Rowntree, Louise C; Hensen, Luca; Subbarao, Kanta; Kedzierska, Katherine; Nicholson, Suellen; Sherry, Norelle; Thevarajan, Irani; Tran, Thomas; Druce, Julian.
  • Audsley JM; Department of Infectious Diseases, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
  • Holmes NE; Department of Infectious Diseases, Austin Hospital, Heidelberg, Australia.
  • Mordant FL; Department of Medicine and Radiology, The University of Melbourne, Australia.
  • Douros C; Data Analytics Research and Evaluation (DARE) Centre, Austin Health and The University of Melbourne, Heidelberg, Australia.
  • Zufan SE; Department of Microbiology and Immunology, University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
  • Nguyen THO; Victorian Infectious Diseases Reference Laboratory, The Royal Melbourne Hospital at The Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
  • Kedzierski L; Microbiological Diagnostic Unit Public Health Laboratory, Department of Microbiology and Immunology, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
  • Rowntree LC; Department of Microbiology and Immunology, University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
  • Hensen L; Department of Microbiology and Immunology, University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
  • Subbarao K; Department of Microbiology and Immunology, University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
  • Kedzierska K; Department of Microbiology and Immunology, University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
  • Nicholson S; Department of Microbiology and Immunology, University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
  • Sherry N; World Health Organisation (WHO) Collaborating Centre for Reference and Research on Influenza, at The Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
  • Thevarajan I; Department of Microbiology and Immunology, University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
  • Tran T; Victorian Infectious Diseases Reference Laboratory, The Royal Melbourne Hospital at The Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
  • Druce J; Microbiological Diagnostic Unit Public Health Laboratory, Department of Microbiology and Immunology, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
Infect Control Hosp Epidemiol ; 43(9): 1286-1288, 2022 09.
Article in English | MEDLINE | ID: covidwho-1240699

Full text: Available Collection: International databases Database: MEDLINE Main subject: Virus Diseases / Middle East Respiratory Syndrome Coronavirus / COVID-19 Limits: Humans Language: English Journal: Infect Control Hosp Epidemiol Journal subject: Communicable Diseases / Nursing / Epidemiology / Hospitals Year: 2022 Document Type: Article Affiliation country: Ice.2021.223

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Virus Diseases / Middle East Respiratory Syndrome Coronavirus / COVID-19 Limits: Humans Language: English Journal: Infect Control Hosp Epidemiol Journal subject: Communicable Diseases / Nursing / Epidemiology / Hospitals Year: 2022 Document Type: Article Affiliation country: Ice.2021.223